211 related articles for article (PubMed ID: 20390425)
1. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Satre-Garau X
J Cancer Res Clin Oncol; 2011 Feb; 137(2):251-9. PubMed ID: 20390425
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
[TBL] [Abstract][Full Text] [Related]
5. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1369-77. PubMed ID: 22488171
[TBL] [Abstract][Full Text] [Related]
6. Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
Pathol Oncol Res; 2014 Apr; 20(2):277-84. PubMed ID: 24022400
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Kotta-Loizou I; Klijanienko J; Giaginis C; Alexandrou P; Dana E; Rodriguez J; Patsouris E; Sastre-Garau X
Tumour Biol; 2014 Jul; 35(7):6455-65. PubMed ID: 24682903
[TBL] [Abstract][Full Text] [Related]
8. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
[TBL] [Abstract][Full Text] [Related]
9. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
10. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
Theocharis S; Kotta-Loizou I; Giaginis C; Alexandrou P; Danas E; Tsourouflis G; Tsoukalas N; Coutts RH; Tasoulas J; Klijanienko J
Anticancer Res; 2017 Mar; 37(3):1313-1319. PubMed ID: 28314297
[TBL] [Abstract][Full Text] [Related]
11. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].
Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY
Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001
[TBL] [Abstract][Full Text] [Related]
12. Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.
Giaginis C; Politi E; Alexandrou P; Sfiniadakis J; Kouraklis G; Theocharis S
Pathol Oncol Res; 2012 Oct; 18(4):875-83. PubMed ID: 22426809
[TBL] [Abstract][Full Text] [Related]
13. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases.
Ling W; Mijiti A; Moming A
J Oral Maxillofac Surg; 2013 Apr; 71(4):775-85. PubMed ID: 23265849
[TBL] [Abstract][Full Text] [Related]
14. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
15. Significance of depth of invasion determined by MRI in cT1N0 tongue squamous cell carcinoma.
Xu C; Yuan J; Kang L; Zhang X; Wang L; Chen X; Yao Q; Li H
Sci Rep; 2020 Mar; 10(1):4695. PubMed ID: 32170092
[TBL] [Abstract][Full Text] [Related]
16. Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue.
Ulanovski D; Stern Y; Roizman P; Shpitzer T; Popovtzer A; Feinmesser R
Oral Oncol; 2004 May; 40(5):532-7. PubMed ID: 15006627
[TBL] [Abstract][Full Text] [Related]
17. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
18. Value of minimal residual disease in patients with early cancer of the tongue.
Ulanovski D; Stern Y; Roizman P; Druzd T; Shpitzer T; Gutman D; Feinmesser R
Am J Otolaryngol; 2004; 25(4):240-4. PubMed ID: 15239029
[TBL] [Abstract][Full Text] [Related]
19. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue.
Lim SC; Zhang S; Ishii G; Endoh Y; Kodama K; Miyamoto S; Hayashi R; Ebihara S; Cho JS; Ochiai A
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):166-72. PubMed ID: 14734465
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
